CHA ÀÇ°úÇдëÇб³ Â÷º´¿ø professor

±³¼ö´Ô»çÁø
  • ±èÀçÈ­
  • ºÐ´çÂ÷º´¿øÀå
  • ¼Ò ¼Ó: ºÐ´çÂ÷º´¿ø
  • Àü¹®ºÐ¾ß : °ß°üÀý/½½°üÀý
  • Á÷ À§: ±³¼ö(ºÐ´çÂ÷º´¿øÀå)
  • ¸Þ ÀÏ: ºñ°ø°³
  • Àü È­: 1577-4488
  • ÆÑ ½º:
  • ÁÖ ¼Ò: °æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßž·Î 59
  • ȨÆäÀÌÁö:
  • ·Î±×ÀÎ

ÅǸ޴º

ÁÖ¿ä¹ßÇ¥³í¹®

ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£ ±¸ºÐ Á¦¸ñ
274 (±¹¿Ü)SCI Osteoporotic Bone Regeneration via Plenished Biomimetic PLGA Sca?old with Sequential Release System
273 (±¹¿Ü)SCI Targeting class A GPCRs for hard tissue regeneration
272 (±¹¿Ü)SCI MicroRNA?606 inhibits the growth and metastasis oftriple?negative breast cancer by targeting Stanniocalcin 1
271 (±¹¿Ü)SCI MicroRNA?606 inhibits the growth and metastasis of triple?negative breast cancer by targeting Stanniocalcin 1
270 (±¹¿Ü)SCI The Effect of the COVID-19 Pandemic on Early Adolescent Fractures in the Republic of Korea
269 (±¹¿Ü)SCI Trabecular structural differencebetween the superior and inferior regions of the vertebral body: a cadaveric and clinical study
268 (±¹¿Ü)SCI miR-4284 Functions as a Tumor Suppressor in Renal CellCarcinoma Cells by Targeting Glutamate Decarboxylase 1
267 (±¹¿Ü)SCI Network analysis of osteoporosis provides a global view of associated comorbidities and their temporal relationships
266 (±¹¿Ü)SCI The effect of teriparatide on fracture healing after atypical femoral fracture: A systematic review and meta-analysis
265 (±¹¿Ü)SCI Comparison of whole trunk muscle mass between healthy and lumbar herniated nucleus pulposus patients using abdominal pelvic computed tomography
ÀÌÀüÆäÀÌÁö À̵¿ 1 2 3 4 5 6 7 8 9 10 ´ÙÀ½ÆäÀÌÁö À̵¿
Copyright ¨Ï chamc, All rights reserved.

ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à

  • °­³²Â÷º´¿ø
  • ºÐ´çÂ÷º´¿ø
  • ºÐ´çÂ÷¿©¼ºº´¿ø
  • ±¸¹ÌÂ÷º´¿ø
  • ¿©¼ºÀÇÇבּ¸¼Ò
  • Â÷¿ò

ÀüÈ­¹®ÀÇ

  • °­³²Â÷º´¿ø 02.3468.3000
  • ºÐ´çÂ÷º´¿ø 031.780.5000
  • Â÷¿ò 02.3015.5300
  • ±¸¹ÌÂ÷º´¿ø 054.450.9700
  • ´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
  • °­³²°ÇÁø¼¾ÅÍ 02.2191.3900
  • ºÐ´çÁ¾ÇÕ°Ç°­ÁõÁø¼¾ÅÍ 031.780.5940
  • ½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
  • ±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
  • ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729